Literature DB >> 32154597

Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease.

Idania Marrero1, Igor Maricic1, Timothy R Morgan2, Andrew A Stolz3, Bernd Schnabl1,4, Zhang-Xu Liu5, Hidekazu Tsukamoto6,7, Vipin Kumar1.   

Abstract

BACKGROUND: Liver is enriched in several innate-like unconventional T cells, but their role in alcohol-related liver disease (ALD) is not fully understood. Studies in several acute alcohol feeding models but not in chronic alcoholic steatohepatitis (ASH) model have shown that invariant natural killer T (iNKT) cells play a pathogenic role in ALD. Here, we investigated the activation of iNKT cells in an intragastric (iG) infusion model of chronic ASH as well as the frequency and cytokine phenotype of 3 different unconventional T cells: iNKT, mucosal-associated invariant T (MAIT), and CD8+ CD161hi Vα7.2- cells in peripheral blood of ALD patients.
METHODS: Hepatic iNKT cells were investigated using the iG model of chronic ASH that combines feeding of high-cholesterol/high-fat diet (HCFD) with intragastric feeding of ethanol diet (HCFD + iG Alc). Human iNKT, MAIT, and CD8+ CD161hi Vα7.2- cells were examined by flow cytometry in peripheral blood of patients with severe alcoholic hepatitis (SAH) and chronic alcoholics (ChA) and compared with healthy controls.
RESULTS: In the iG model of chronic ASH, IFNγ+ iNKT cells accumulate in their livers compared with pair-fed control mice and activated hepatic iNKT cells show high expression of Fas and FasL. Notably, IFNγ+ iNKT cells are also significantly increased in peripheral blood of ChA patients compared with SAH patients. MAIT cells are significantly reduced in all ALD patients, but CD8+ CD161hi Vα7.2- cells are increased in SAH patients. Although MAIT and CD8+ CD161hi Vα7.2- cells displayed a similar cytokine production profile, the production of IFNγ and TNFα is significantly increased in SAH patients, while significant IL-17A production is found in ChA patients.
CONCLUSIONS: We found that the 3 unconventional T cells are activated in ALD patients showing interesting differences in their frequency and cytokine production profile between SAH and ChA patients. In the iG murine model of chronic ASH, iNKT cells are also activated secreting proinflammatory cytokines suggesting their involvement in liver disease.
© 2020 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol-Related Liver Disease; CD8; Chronic Alcoholic; IFNγ; iG ASH Model

Year:  2020        PMID: 32154597      PMCID: PMC7211132          DOI: 10.1111/acer.14323

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  66 in total

1.  Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.

Authors:  Philomena Arrenberg; Ramesh Halder; Yang Dai; Igor Maricic; Vipin Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

Authors:  Jordi Colmenero; Ramón Bataller; Pau Sancho-Bru; Pablo Bellot; Rosa Miquel; Montserrat Moreno; Pedro Jares; Jaime Bosch; Vicente Arroyo; Joan Caballería; Pere Ginès
Journal:  Gastroenterology       Date:  2006-12-20       Impact factor: 22.682

3.  The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis.

Authors:  Thomas Sersté; Alexia Cornillie; Hassane Njimi; Marco Pavesi; Vicente Arroyo; Antonella Putignano; Laura Weichselbaum; Pierre Deltenre; Delphine Degré; Eric Trépo; Christophe Moreno; Thierry Gustot
Journal:  J Hepatol       Date:  2018-03-08       Impact factor: 25.083

Review 4.  Alcoholic liver disease and the gut-liver axis.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

Review 5.  Liver antigen-presenting cells.

Authors:  Ian Nicholas Crispe
Journal:  J Hepatol       Date:  2010-10-16       Impact factor: 25.083

Review 6.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

Review 7.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

Review 8.  Endotoxemia and gut barrier dysfunction in alcoholic liver disease.

Authors:  Radhakrishna Rao
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

9.  ACG Clinical Guideline: Alcoholic Liver Disease.

Authors:  Ashwani K Singal; Ramon Bataller; Joseph Ahn; Patrick S Kamath; Vijay H Shah
Journal:  Am J Gastroenterol       Date:  2018-01-16       Impact factor: 10.864

10.  Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury.

Authors:  Peng Chen; Yukiko Miyamoto; Magdalena Mazagova; Kuei-Chuan Lee; Lars Eckmann; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-11-11       Impact factor: 3.455

View more
  5 in total

Review 1.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

Review 2.  Immunological mechanisms and therapeutic targets of fatty liver diseases.

Authors:  Hua Wang; Wajahat Mehal; Laura E Nagy; Yaron Rotman
Journal:  Cell Mol Immunol       Date:  2020-12-02       Impact factor: 11.530

Review 3.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

Review 4.  A mini-review of the rodent models for alcoholic liver disease: shortcomings, application, and future prospects.

Authors:  Shi-Xuan Liu; Yan-Chao Du; Tao Zeng
Journal:  Toxicol Res (Camb)       Date:  2021-05-10       Impact factor: 3.524

Review 5.  Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.